Literature DB >> 26363750

Acute coronary syndrome due to midazolam use: Kounis syndrome during a transurethral prostatectomy.

Ahmet Hakan Ateş1, Selim Kul2.   

Abstract

Developments in the drugs industry are leading to more rare drug side effects being encountered in clinical practice. Of these side effects, allergic reactions and hypersensitivity are seen in the usage of a large group of drugs such as antibiotics, analgesics, antineoplastics, contrast agents, corticosteroids, intravenous anesthetics, nonsteroidal anti-inflammatory drugs, and proton pump inhibitors. One important result of these reactions is acute coronary syndrome, which may have serious life-threatening results. This syndrome was first described in 1991 by Kounis as an 'allergic angina syndrome progressing to acute myocardial infarction', and thereafter called 'allergic myocardial infarction'. This case report presents a 70-year-old male who had angina and dyspnea after administration of midazolam at the beginning of a transurethral prostatectomy operation.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26363750     DOI: 10.5543/tkda.2015.44567

Source DB:  PubMed          Journal:  Turk Kardiyol Dern Ars        ISSN: 1016-5169


  3 in total

1.  Midazolam anaphylaxis during general anesthesia: A case report.

Authors:  Yeon Su Jeon; JinWoo Shim; Eun Hwa Jun; Seung Tae Choi; Hong Soo Jung
Journal:  Medicine (Baltimore)       Date:  2019-10       Impact factor: 1.817

2.  Hypersensitivity reaction to midazolam: a case of cardio-respiratory failure.

Authors:  Eleonora Nucera; Arianna Aruanno; Alessandro Buonomo; Giuseppe Parrinello; Angela Rizzi
Journal:  Postepy Dermatol Alergol       Date:  2021-01-06       Impact factor: 1.837

3.  Comparing the impact on the prognosis of acute myocardial infarction critical patients of using midazolam, propofol, and dexmedetomidine for sedation.

Authors:  Xiaowei Jiang; Min Yan
Journal:  BMC Cardiovasc Disord       Date:  2021-12-07       Impact factor: 2.298

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.